Exosome Consulting’s Post

#WRIB is in full swing and Steve Lowes, Richard Snyder, Sara Brady, Rickerson Felix, MBA, and the rest of the Q2 Team are excited to meet with you and talk about your upcoming plans and/or help you overcome scientific, quality, deliverables, or other challenges. Want to set up a time to meet here at WRIB, or if you’re not attending and want to chat, just click here: https://lnkd.in/eRPJS6Uz #drugmetabolism #pharmacokinetics #lifescience #invitro #biotransformation #dmpk #pharma #biotech #research #drugdevelopment #bioanalysis #bioanalytical #immunoassay #lcmsms #lcms #hrms #pharma #adme #oligonucleotides #monoclonalantibodies #rnabasedtherapeutics

When you travel, do you follow the guidebook or go off the beaten path? Get the best of both worlds with CovalX's ICH Q6B Analysis Services. Letting you gain innovative advantages even while you comply.  Embark on a journey of discovery with CovalX's ICH Q6B Analysis Services: ☑️Get help with your IND submission. ☑️Improve on your protein characterization. ☑️Access advanced orthogonal techniques for your IND.  ☑️Navigate regulations with experienced travelers by your side. Realize the potential of exciting new protein therapeutics. Join the Adventure https://hubs.ly/Q02FtYV-0 #ICHQ6B #Biopharma #ProteinAnalysis #Covalx

📢Maximize Market Dominance with QTL Technology Recent developments in biologic therapeutics have led to technical challenges in scaling up production for new indications. However, advances in QTL-enabled recombinant protein projects provide opportunities for additional patent protection. Upgrading manufacturing processes and optimizing aspects of production can lead to cost reduction and market dominance. It is crucial to avoid the risks associated with outdated manufacturing approaches and ensure the feasibility and investor interest in biosimilar projects. QTL technology offers tailored solutions and extended patent protection, making it a valuable tool in the market. #BioprocessUpdates #patentprotection #biosimilars #biologictherapeutics #scalingup #production #QTLtechnology #recombinantprotein #costreduction #marketdominance #manufacturingapproaches #feasibility #investorinterest #tailoredsolutions #extendedpatentprotection #valuabletool ▷ Read the full article here: 📎 https://lnkd.in/dRb8bd9K

Beginning the year updating the Ubiquigent 2024 Research Tools catalogue 📣 Did you know we sell high-quality reagents to support #ubiquitin-system research? We have 100s of validated reagents including DUBs and their substrates, Ubiquitin substrates, chains & binding proteins, E1 / E2 #enzymes & E3 #ligases, #proteosome, #kinases and much more.  Useful to discover the next clinical DUB inhibitor/modulator or in #TPD and developing #PROTAC® Importantly, and what provides our users confidence, we utilise many of these products in our platform to support clients and partners or drive our internal R&D goals. You can check out the list attached or click here https://lnkd.in/gcyyVxHe to find out more. Any questions just ask. #deubiquitinases #DrugDiscovery #DrugDevelopment #DUB #DUBTAC #E3Ligase #TargetedProteinDegradation #research #pharma #biotech

Forbion portfolio company Orbis Medicines, a leader in oral macrocycle drug discovery, has entered into a research collaboration and option to an exclusive license with Vivtex, a biotech company revolutionizing oral biologic therapies. This partnership will empower Orbis to leverage Vivtex's cutting-edge GI-ORIS™ platform for gut permeability screening, helping to assess the oral bioavailability of Orbis’ next-generation macrocycle drugs, also known as ‘nCycles’. This collaboration could open the door to groundbreaking advancements in the development of orally available therapies for major diseases. Stay tuned for more updates as they advance this exciting science! #Forbion #PortfolioCompany #OralMedicines #OrbisMedicines #Biotech #DrugDiscovery #nCycles #Vivtex #GIORIS #InnovationInHealthcare Marco Boorsma Tim Lohoff, Ph.D. Vanessa Carle Click on the following link to read the official release: https://lnkd.in/e3F-D8Zv

Approach us for your Discovery Solutions !!! Transform your R&D journey with our cutting-edge discovery solutions. Whether you're in biotech, pharmaceuticals, or academia, our expertise accelerates innovation. Reach out today and let's pioneer the future together. #DiscoverySolutions #Innovation #ResearchAndDevelopment #DrugDiscovery  #Research  #Development  #CRO  #CRAMS  #BuildingBlocks  #linkedin  #linkedincommunity #PROTAC  #Ligands  #Linkers  #protein  #ligand  #Medchem  #MedicinalChemistry  #PROTACs  #Innovation  #Targeted  #Protein  #drug  #discovery #combi  #dmf  #fte  #blocks  #Novel  #Approach  #Crosslinker   #Portfolio  #proteolysis #Ligase  #synthetic  #Linker  #smallmolecule  #compounds  #CDMO  #CRDMO  #CMO #oursoucing  #chemicalindustry  #drugdiscovery  #medchem  #express  #medicinalchemistry #organic  #chemistry  #api  #innovation  #ligands  #scaffold  #medchemexpress  #chemtech

The highly popular poster presented at WRIB 2024 by Jing L., Principal Scientist on Anti-Drug Antibody (ADA) Assay for Xpro 1595, A Self-Assembling Trimer: Alternative to Standard Bridging Approach is now available for viewing here with no waiting! https://bit.ly/4cDA0Dx #drugmetabolism #pharmacokinetics #lifescience #invitro #biotransformation #dmpk #pharma #biotech #research #drugdevelopment #bioanalysis #bioanalytical #immunoassay #lcmsms #lcms #hrms #pharma #adme #oligonucleotides #monoclonalantibodies #rnabasedtherapeutics

It didn't happen overnight. We're a bioanalytical CRO with multiple decades of experience that you can trust. Let's connect: https://bit.ly/3pnaTlm #cro #bioanalysis #biotech #pharma #science #spatialbiology

 Product of the week : (Z)-6-Hydroxyhex-3-en-1-yl 4-methylbenzenesulfonate CAS No.： 72530-34-8 Approach us for your Discovery Solutions!!! Transform your R&D journey with our cutting-edge discovery solutions. Whether you're in biotech, pharmaceuticals, or academia, our expertise accelerates innovation.Reach out today and let's pioneer the future together. #DiscoverySolutions  #Innovation #ResearchAndDevelopment #CRO #DrugDiscovery  #Research #Development  #CRAMS #linkedin #PROTAC #BuildingBlocks  #linkedincommunity  #Ligands #Linkers  #protein  #ligand #Medchem  #MedicinalChemistry #PROTACs #Innovation  #Targeted  #Protein  #drug #discovery #combi #dmf #fte #blocks  #Novel  #Approach #Crosslinker #Portfolio #proteolysis #Ligase #synthetic #Linker #smallmolecule#compounds  #CDMO#CRDMO  #CMO  #outsourcing  #chemicalindustry #drugdiscovery #medchem  #express   #medicinalchemistry  #organic  #chemistry #ligands  #scaffold  #medchemexpress #chemtech

ICYMI: Recent research highlights the critical role of N-terminal acetylation by N-terminal acetyltransferases (NATs) in shaping protein lifespan. This insight offers promising pathways for targeted drug development. Read more on our blog: https://lnkd.in/eTrMXHzU